Literature DB >> 28660443

Isoforms of TGF-β in the aqueous humor of patients with pseudoexfoliation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.

Justus G Garweg1,2, Souska Zandi3, Christin Gerhardt3,4, Isabel B Pfister3,4.   

Abstract

BACKGROUND: Pseudoexfoliation syndrome (PEXS) may go along with capsular bag shrinkage and luxation. In the present study, we focus on an association of isoforms of TGF-β with capsular bag luxation.
METHODS: Aqueous humor was collected intraoperatively from 20 healthy controls and from 73 otherwise healthy patients with PEXS [PEXS without complications (PEX, n = 33), late PEXS with glaucoma (PEXG, n = 30) and with IOL and capsular bag luxation (PEXL, n = 10)]. The concentrations of TGF-β1, TGF-β2 and TGF-β3 were compared using the Bio-Plex® multiplex beads system based on the non-parametric Kruskal-Wallis H test (p < 0.01).
RESULTS: Concentrations of TGF-β 1, TGF-β 2 and TGF-β 3 were higher in the sub-groups PEX and PEXG than in controls (TGF-β 1; p = 0.009 and 0.0005; TGF-β 2; p = 0.002 and 0.005 and TGF-β 3; 0.0005 and 0.0005; respectively), whereas for TGF β2, no significant difference between controls and PEXL was revealed (p = 1.0). TGF-β2 concentrations were elevated in a similar degree in early PEX and PEXG, but not in PEXL compared to controls (p = 0.002). The concentrations of of TGF-β 1 and TGF-β 3 increased in parallel with the progression of disease. The levels of TGF-β 3, however, did not attain pathophysiological levels (>100 pg/ml) in any group.
CONCLUSIONS: A stage-dependent increase in the concentrations of TGF-β1 and TGF-β3, but not of TGF-β2, accords to the shrinkage of the capsular bag. This could increase the tension on the zonular fibers and contribute to luxation of the capsular bag.

Entities:  

Keywords:  Aqueous humor; Biomarkers; Chemokines; Cytokines; Isoforms of transforming growth factor-β (TGF-β); PEX; Pseudoexfoliation glaucoma; Pseudoexfoliation syndrome; TGF-β1; TGF-β2; TGF-β3

Mesh:

Substances:

Year:  2017        PMID: 28660443     DOI: 10.1007/s00417-017-3724-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  33 in total

1.  Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.

Authors:  Matthias Zenkel; Friedrich E Kruse; Anselm G Jünemann; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation.

Authors:  Huseyin Simavli; Mehmet Tosun; Yasin Y Bucak; Mesut Erdurmus; Zeynep Ocak; Halil I Onder; Muradiye Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-10       Impact factor: 3.117

3.  Pathologic evidence of pseudoexfoliation in cases of in-the-bag intraocular lens subluxation or dislocation.

Authors:  Erica Liu; Scott Cole; Liliana Werner; Fritz Hengerer; Nick Mamalis; Thomas Kohnen
Journal:  J Cataract Refract Surg       Date:  2015-04-29       Impact factor: 3.351

4.  Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular Holes.

Authors:  Souska Zandi; Christoph Tappeiner; Isabel B Pfister; Alain Despont; Robert Rieben; Justus G Garweg
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

5.  Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.

Authors:  Matthias Zenkel; Anita Krysta; Francesca Pasutto; Anselm Juenemann; Friedrich E Kruse; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

6.  Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract.

Authors:  Yasuyuki Takai; Masaki Tanito; Akihiro Ohira
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

7.  Pseudoexfoliation in the reykjavik eye study: five-year incidence and changes in related ophthalmologic variables.

Authors:  Arsaell Arnarsson; Karim F Damji; Hiroshi Sasaki; Thordur Sverrisson; Fridbert Jonasson
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258

8.  Distribution of pseudoexfoliation material on anterior segment structures in human autopsy eyes after cataract surgery with intraocular lens implantation.

Authors:  Ingo Schmack; Gerd Uwe Auffarth
Journal:  Int Ophthalmol       Date:  2015-08-26       Impact factor: 2.031

9.  MALDI MS imaging analysis of apolipoprotein E and lysyl oxidase-like 1 in human lens capsules affected by pseudoexfoliation syndrome.

Authors:  Maurizio Ronci; Shiwani Sharma; Sarah Martin; Jamie E Craig; Nicolas H Voelcker
Journal:  J Proteomics       Date:  2013-02-11       Impact factor: 4.044

10.  Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts.

Authors:  Samin Hong; Sueng-Han Han; Chan Yun Kim; Kang Yoon Kim; Yoo Kyung Song; Gong Je Seong
Journal:  BMC Ophthalmol       Date:  2015-05-28       Impact factor: 2.209

View more
  11 in total

1.  Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1.

Authors:  Heather M Schmitt; William M Johnson; Inas F Aboobakar; Shelby Strickland; María Gomez-Caraballo; Megan Parker; Laura Finnegan; David L Corcoran; Nikolai P Skiba; R Rand Allingham; Michael A Hauser; W Daniel Stamer
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

Review 2.  Multiplex protein analysis for the study of glaucoma.

Authors:  Gülgün Tezel
Journal:  Expert Rev Proteomics       Date:  2021-10-29       Impact factor: 3.940

3.  Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma.

Authors:  Justus G Garweg; Souska Zandi; Isabel B Pfister; Magdalena Skowronska; Christin Gerhardt
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

4.  Biomarkers for PVR in rhegmatogenous retinal detachment.

Authors:  Souska Zandi; Isabel B Pfister; Peter G Traine; Christoph Tappeiner; Alain Despont; Robert Rieben; Magdalena Skowronska; Justus G Garweg
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

5.  Aqueous autotaxin and TGF-βs are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes.

Authors:  Nozomi Igarashi; Megumi Honjo; Ryo Asaoka; Makoto Kurano; Yutaka Yatomi; Koji Igarashi; Kazunori Miyata; Toshikatsu Kaburaki; Makoto Aihara
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

6.  Evaluation of the White-to-White Distance in 39,986 Chinese Cataractous Eyes.

Authors:  Ling Wei; Wenwen He; Jiaqi Meng; Dongjin Qian; Yi Lu; Xiangjia Zhu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

7.  Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations.

Authors:  Souska Zandi; Isabel B Pfister; Justus G Garweg
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

8.  The Effect of Amniotic Membrane Transplantation on Trabeculectomy in Patients with Pseudoexfoliation Glaucoma.

Authors:  Huikyung Kim; Sangwoo Moon; Jinmi Kim; Jiwoong Lee
Journal:  J Ophthalmol       Date:  2022-07-30       Impact factor: 1.974

9.  Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor.

Authors:  Mengxuan Liu; Megumi Honjo; Reiko Yamagishi; Nozomi Igarashi; Natsuko Nakamura; Makoto Kurano; Yutaka Yatomi; Koji Igarashi; Makoto Aihara
Journal:  Biomolecules       Date:  2022-09-03

10.  Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines.

Authors:  Isabel B Pfister; Souska Zandi; Christin Gerhardt; Jan Spindler; Natalie Reichen; Justus G Garweg
Journal:  Transl Vis Sci Technol       Date:  2020-06-24       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.